Sinopharm Accord

200028

12.800.00% ( 0.00 )

Delay Closed: Nov 13, 15:00:00

Current ValuationThe current P/E ratio is 5.89, within the reasonable range, cheaper than 25.57% of the time in the past 5 years, and the industry ranks 1/27, the industry Median 12.74.

5.89xP/E

Stock priceHK$12.80Earnings per shareHK$2.17

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 12.74x

0481216

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 12.74x

0x40x80x120x160x200x

P/E ratio
Name/Symbol
601607SHShanghai Pharma	11.58x	5.26%	HK$59.82B
000963SZHUADONG MEDICINE	13.22x	1.36%	HK$45.44B
600332SHGYBYS	14.53x	17.74%	HK$31.46B
600998SHJointown	13.08x	2.27%	HK$25.67B
600511SHSINOPHARM(CNCM LTD)	10.81x	5.06%	HK$21.41B
200028SZSinopharm Accord	5.89x	--	HK$7.84B
000028SZSinopharm Accord	11.26x	8.67%	HK$12.73B
600211SHTIBET PHARMA	12.74x	--	HK$12.64B
600713SHNPGC	10.66x	--	HK$6.80B
603368SHGUANGXI LIUYAO GROUP	10.42x	4.47%	HK$6.47B
000411SZINT'L GROUP	11.27x	--	HK$5.39B
002788SZLUYAN PHARMA	13.24x	--	HK$3.62B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.